STRAIN OF BACTERIUM SALMONELLA TYPHIMURIUM T-10 BMC160 FOR IMMUNIZATION AGAINST HUMAN IMMUNODEFICIENCY VIRUS Russian patent published in 2002 - IPC

FIELD: medicine, immunology, microbiology. SUBSTANCE: strain Salmonella typhimurium T-10 BMC160 is obtained from the strain Salmonella typhimurium T-10. Using genetic transformation plasmid pBMC160 providing synthesis of protein g160 of human immunodeficiency virus is incorporated into the parent strain. Strain Salmonella typhimurium T-10 BMC160 shows high capacity to induce expressed and effective immunization to human immunodeficiency virus. Strain is used for development of immunity against human immunodeficiency virus. EFFECT: valuable properties of strain. 3 tbl, 3 ex